Grossman Jessica D. 4

What Happened

• Jessica D. Grossman, a director of Dare Bioscience, was granted 26,066 restricted stock units (RSUs) on June 30, 2026. The grant is reported at an acquisition price of $0.00 (standard for RSU awards), so no cash was exchanged in the filing. These RSUs were awarded in lieu of cash compensation for her board and committee service.

Key Details

• Transaction date and price: June 30, 2026; grant recorded at $0.00 per RSU.
• Shares received: 26,066 RSU awards (each RSU represents the right to receive one share upon vesting).
• Vesting: RSUs vest on January 4, 2027 (per footnote).
• Shares owned after transaction: not specified in the filing.
• Filing date: July 2, 2026 — appears to be timely (Form 4s are generally due within two business days of the transaction).
• Footnote: The RSUs were granted in lieu of cash compensation for board service.

Context

• RSU awards are a form of compensation, not an open‑market purchase or sale, and typically reflect routine director pay rather than a direct market sentiment signal. Once vested (Jan 4, 2027), each RSU converts to one share (subject to any withholding or other plan terms).